Revolution Medicines, Inc. (RVMD) Financials
RVMD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 2.1 billion | 262.4 million |
2023-09-30 | 984.2 million | 146.8 million |
2023-06-30 | 1.1 billion | 142.9 million |
2023-03-31 | 1.1 billion | 121.0 million |
RVMD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -122.9 million | 25.4 million |
2023-09-30 | -103.0 million | 13.7 million |
2023-06-30 | -68.2 million | 13.0 million |
2023-03-31 | -64.1 million | 9.7 million |
RVMD Net Income
No data available :(
RVMD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.9 billion | - | 87.9 million |
2023-09-30 | 813.2 million | - | 62.8 million |
2023-06-30 | 909.5 million | - | 63.3 million |
2023-03-31 | 909.8 million | - | 63.6 million |
RVMD Shares Outstanding
RVMD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.3 million | 146.9 million | 32.2 million | 1.2 million |
2023-09-30 | 2.5 million | 107.7 million | 15.5 million | - |
2023-06-30 | 1.1 million | 98.0 million | 14.6 million | - |
2023-03-31 | 1.8 million | 68.9 million | 13.2 million | - |
RVMD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 742000 | 2.9 million |
2023-09-30 | - | 2.1 million |
2023-06-30 | 3.8 million | 1.8 million |
2023-03-31 | 7.0 million | 2.5 million |
RVMD
Price: $37.28
52 week price:
Earnings Per Share: -3.86 USD
P/E Ratio: -9.17
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 856800
Market Capitalization: 5.9 billion